Allen Radin,Neil Graham,Bolanle Akinlade,Gianluca Pirozzi,Xing Sun,Thomas Hultsch,Brad S. Shumel,Ashish Bansal
申请号：
US15711815
公开号：
US10485844B2
申请日:
2017.09.21
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention provides methods for treating moderate-to-severe or severe atopic dermatitis (AD). The methods of the present invention comprise administering to a subject in need thereof one or more doses of an interleukin-4 receptor (IL-4R) inhibitor such as an anti-IL-4R antibody. In certain embodiments, the methods of the present invention are used to treat severe AD in a patient whose disease is not controlled with systemic therapy (e.g., cyclosporine A) or when such therapy is inadvisable.
